BioArctic's partner Eisai presents updated sales simulation for Leqembi® at its annual press conference
Barnes Group, Inc. (B)
Last barnes group, inc. earnings: 4/24 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
ir.barnesgroupinc.com/investor-relations/overview/default.aspx
Company Research
Source: PR Newswire
STOCKHOLM, March 7, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq: BIOA B) (Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for Leqembi, the world's first fully approved disease-modifying treatment for Alzheimer's disease. According to Eisai's simulation, Leqembi sales will reach JPY 290 billion for their financial year (FY) 2026, which ends in March 2027 and JPY 1.6 trillion in FY2032.Eisai's presentation can be found on https://www.eisai.com/ir/library/presentations/index.html.This information is information that BioArctic AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons below, on March 7, 2023, at 06:30 a.m. CET.For further information, please contact: Oskar Bosson, VP Communications and IRE-mail: oskar.bosson@bioarctic.comPhone: +46 70 410 71 80 Jiang Millington, Director Corporate Commun
Show less
Read more
Impact Snapshot
Event Time:
B
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
B alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
B alerts
High impacting Barnes Group, Inc. news events
Weekly update
A roundup of the hottest topics
B
News
- Barnes Group (B) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]Yahoo! Finance
- Barnes Group (B) Q1 Earnings and Revenues Top Estimates [Yahoo! Finance]Yahoo! Finance
- Barnes Reports First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Barnes Reports First Quarter 2024 Financial ResultsBusiness Wire
- Barnes Group Inc. (NYSE: B) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $45.00 price target on the stock, up previously from $35.00.MarketBeat
B
Earnings
- 4/26/24 - Beat
B
Sec Filings
- 4/26/24 - Form 8-K
- 4/4/24 - Form 8-K
- 3/29/24 - Form ARS
- B's page on the SEC website